Related Experiment Video
Updated: Jan 7, 2026

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
Published on: September 20, 2018
Clinical Manifestations
Yonatan M Schwartz1, Michal S Beeri2, Sharon Naparstek1
1Bar-Ilan University, Ramat Gan, Israel.
Background:
The Cognitive Reserve (CR) theory posits that intellectual enrichment, such as education, enhances brain efficiency, enabling individuals to withstand more neurodegeneration and delay cognitive decline. However, CR does not slow disease progression, potentially leading to a faster decline once impairment begins. This study examined CR's impact on cognitive performance over time in middle-aged adults at increased risk for Alzheimer's Disease (AD).
Method:
Two hundred and twenty-five middle-aged adults (129 females; ages 40-66 years, M=54.8, SD=6.8; education 11-27 years, M=16.5, SD=3.02) with AD parental history from the Israel Registry for Alzheimer's Prevention study underwent baseline cognitive assessments and brain MRI scans, followed by a cognitive reassessment 2.5-11.2 years later (M=6.5, SD=2.1). CR was measured by baseline vocabulary, and cognitive function was evaluated across working memory, episodic memory, attention/processing speed, and reasoning/problem-solving. Mediation analyses assessed baseline cognitive function as a mediator of follow-up outcomes, controlling for sex, age, education, intracranial volume, brain atrophy, and the time interval between assessments.
Result:
Higher CR was positively associated with baseline performance in working memory (β = .16, p < .01), episodic memory (β = .25, p < .001), attention/processing speed (β = .34, p < .001), and reasoning/problem-solving (β = .45, p < .001), with similar indirect associations at follow-up (β = .11, p < .01 to β = .35, p < .001), mediated by baseline performance. However, higher CR predicted greater cognitive decline in working memory (β=-.17, p < .02), episodic memory (β=-.12, p < .001), attention/processing speed (β=-.17, p < .001), and reasoning/problem-solving (β=-.11, p < .01), with these effects mediated by baseline performance except in working memory, where the effect was largely direct.
Conclusion:
These findings suggest that CR compensates for the functional decline caused by brain atrophy but does not delay its progression. This compensatory effect is evident in its ability to maintain cognitive performance and postpone decline temporarily. However, once cognitive decline begins, it tends to occur more rapidly. These results underscore the need for early interventions targeting the root causes of cognitive deterioration to reduce the long-term impact of disease progression.
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Coronary Artery Disease III: Clinical Manifestations
Endocarditis II: Clinical Features of Infective Endocarditis
Heart Failure III: Clinical Manifestations
Gastroesophageal Reflux Disease II: Clinical Features and Management
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Hypertension III: Clinical Manifestations and Diagnostic Studies

